See sub navigation
- 4.1 Financial Review
- FINANCIAL STATEMENTS
- 4.2 Consolidated Financial Statements
-
4.3 Notes to the Consolidated Financial Statements
- 4.3.1 Financial Highlights
- 4.3.2 Operating Segments and Directional Reporting
- 4.3.3 Revenue
- 4.3.4 Other Operating Income and Expense
- 4.3.5 Expenses by Nature
- 4.3.6 Employee Benefit Expenses
- 4.3.7 Research and Development Expenses
- 4.3.8 Net Impairment Gains/(Losses) on Financial and Contract Assets
- 4.3.9 Net Financing Costs
- 4.3.10 Income Tax Expense
- 4.3.11 Earnings/(Loss) Per Share
- 4.3.12 Dividends Paid and Proposed
- 4.3.13 Property, Plant and Equipment
- 4.3.14 Intangible Assets
- 4.3.15 Finance Lease Receivables
- 4.3.16 Other Financial Assets
- 4.3.17 Deferred Tax Assets and Liabilities
- 4.3.18 Inventories
- 4.3.19 Trade and Other Receivables
- 4.3.20 Construction Work-In-Progress
- 4.3.21 Derivative Financial Instruments
- 4.3.22 Net Cash and Cash Equivalent
- 4.3.23 Equity Attributable to Shareholders
- 4.3.24 Borrowings and Lease Liabilities
- 4.3.25 Deferred Income
- 4.3.26 Provisions
- 4.3.27 Trade and Other Payables
- 4.3.28 Commitments and Contingencies
- 4.3.29 Financial Instruments − Fair Values and Risk Management
- 4.3.30 List of Group Companies
- 4.3.31 Investment in Associates and Joint Ventures
- 4.3.32 Information on Non-controlling Interests
- 4.3.33 Related Party Transactions
- 4.3.34 Independent Auditor’s Fees and Services
- 4.3.35 Events After End of Reporting Period
- 4.4 Company Financial Statements
- 4.5 Notes to the Company Financial Statements
- 4.6 Other information
- 4.7 Key Figures
- NON-FINANCIAL INFORMATION
- 4.8 Scope of Non-Financial Information
- 4.9 Reporting Boundaries
- 4.10 Non-Financial Indicators
- 4.11 GRI Content Index
- 4.12 Certification and Classification Tables
- 4.13 Assurance Report of the Independent Auditor
4.3.29Financial Instruments − Fair Values and Risk Management
This note presents information about the Company’s exposure to risk resulting from its use of financial instruments, the Company’s objectives, policies and processes for measuring and managing risk, and the Company’s management of capital. Further qualitative disclosures are included throughout these consolidated financial statements.